Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial - Bailón L; Moltó J; Curran A; Cadiñanos J; Carlos Lopez Bernaldo de Quirós J; de Los Santos I; Ambrosioni J; Imaz A; Benet S; Suanzes P; Navarro J; González-García J; et al. (Nature Communications, 2025)